Long-term Nutropin Therapy Enhances Growth in American Males with Noonan Syndrome
Reading Time: 2 minutesIntroduction Noonan Syndrome, a genetic disorder characterized by distinctive facial features, congenital heart defects, and short stature, poses significant challenges in the management of affected individuals. Among the therapeutic interventions, Nutropin, a recombinant human growth hormone, has been employed to address the growth deficits associated with this syndrome. This article presents a comprehensive retrospective analysis of the long-term outcomes of... Read more »

